Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ covaxin 81% effective ]

Results 1 to 11 of 11
Reuters
March 16, 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States


BusinessToday.In
March 4, 2021
Bharat Biotech published the interim efficacy report of phase 3 clinical trial on its COVID-19 vaccine, officially known as Covaxin. The indigenous COVID-19 vaccine is found to be 81 per cent effective in preventing the virus


Reuters
March 4, 2021
Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said


Rashi Bisaria
New Delhi, March 4, 2021
Digital media norms to be administered by Centre, not states The Information and Broadcasting (I&B) Ministry on Wednesday issued memorandum to states and union territories saying that the new rules for digital news publishers and over-the-top (OTT) platforms are to be administered by the Centre, not the states. The government had notified the Information Technology (Intermediary Guidelines and Digital Media Ethics Codes) Rules, 2021 on February 25. Defence equipment sales to India sho...


BusinessToday.In
March 4, 2021
Very early this morning, our first half a million doses of the AstraZeneca-Oxford vaccine from the Serum Institute arrived in Canada, said Prime Minister Justin Trudeau


PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy


BusinessToday.In
March 3, 2021
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


BusinessToday.In
March 3, 2021
Meanwhile, consulting and processing services provider Accenture also said that it will cover the cost for employees and dependents eligible for vaccination.


Joe C Mathew
March 3, 2021
The interim efficacy trend of 81 per cent, analysed as per the protocol approved by the Drugs Controller General of India, puts it at par with other global front-runner vaccines, stated ICMR


BusinessToday.In
March 3, 2021
Data from 25,800 participants who received a vaccine or placebo in 1:1 ratio showed that the vaccine was well-tolerated; Bharat Biotech said the trial conducted with ICMR was the largest in India


BusinessToday.In
January 15, 2021
Ten of these states have already received 20,000 doses of Covaxin, while Assam has so far got 12,000 doses


PAGES 1 OF 1